NasdaqGS:SRPTBiotechs
A Look At Sarepta Therapeutics (SRPT) Valuation After New Shelf Registration For Potential Share Offering
Sarepta Therapeutics (SRPT) has filed a shelf registration for up to US$342 million in common shares, tied to an ESOP related offering, which puts potential share issuance and future capital needs in focus for investors.
See our latest analysis for Sarepta Therapeutics.
The shelf registration lands after a difficult stretch for holders, with the share price down 31.61% over the last month and the 1 year total shareholder return falling 63.38%. This suggests sentiment has weakened despite...